Watch Ticker

Akari Therapeutics plc ADR (0.01 USD)

Go to Akari Therapeutics plc ADR (0.01 USD) Website

$0.98

0.00 (0.00%)

Live

Previous Close

$0.985

Day Range

$0 - $0

Previous Day Range

$0.973998 - $1

Market Cap

$32.1 million USD

Day Vol.

Previous Day Vol.

31184

Currency

USD

Primary Exchange

Nasdaq

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transfor...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio

Akari Therapeutics has successfully completed the merger with Peak Bio, creating an innovative biotechnology company focused on developing therapies for autoimmune and inflammatory diseases. The combined entity secured $3.2 million in PIPE financing and a $50 million term sheet for an equity line of credit to support its pipeline development.

Related tickers: AKTX.

Read Full Article

Akari Therapeutics Plc - Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024

Related tickers: AKTX.

Read Full Article

Trending Tickers

Please sign in to view